Updated:
Fontus Capital
Fontus Capital invests in life science and medical enterprises that promote human health. The firm provides funding to companies developing delivery platforms...
Fontus Capital
Fontus Capital invests in life science and medical enterprises that promote human health. The firm provides funding to companies developing delivery platforms and scalable drug discovery engines. Fontus Capital is involved with Rona Therapeutics, which has completed a $33 million Series A financing to advance its delivery platform and initial pipeline of therapeutics.
General information
Firm type
Private Equity
Year founded
2015
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
What investment stages does Fontus Capital typically target?
Fontus Capital invests across the venture and growth equity spectrum, from early-stage seed rounds and start-up phases to later expansion and growth-stage financings. The firm's mandate allows it to support companies from their initial market entry through to more mature private capital raises.
Does Fontus Capital participate in fund commitments or only direct deals?
The firm's known strategy is centered on direct equity investments in private companies, with no public evidence of a fund-of-funds or LP commitment program. Its operations are structured around direct venture and growth-stage placements.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: